Raymond James Financial’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.56M Sell
202,276
-47,387
-19% -$1.56M ﹤0.01% 2653
2026
Q1
$9.32M Buy
249,663
+36,991
+17% +$1.52M ﹤0.01% 2083
2025
Q4
$9.98M Buy
212,672
+8,568
+4% +$371K ﹤0.01% 1968
2025
Q3
$8.55M Buy
204,104
+43,009
+27% +$1.89M ﹤0.01% 2053
2025
Q2
$7.09M Sell
161,095
-251,404
-61% -$11.4M ﹤0.01% 2135
2025
Q1
$20.8M Buy
412,499
+283,238
+219% +$14M 0.01% 1274
2024
Q4
$5.55M Buy
+129,261
New +$5.45M ﹤0.01% 2261

Other funds holding G

Raymond James Financial's G Position: Q2 2026 in Review

Raymond James Financial reduced its Genpact (G) stake by 19% in Q2 2026, selling an estimated $1.56M and leaving 202,276 shares worth $5.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

Raymond James Financial first reported a position in G in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.8M in Q1 2025. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Raymond James Financial held 202,276 shares of Genpact worth $5.56M as of Q2 2026.
  • Raymond James Financial sold 47,387 Genpact shares in Q2 2026, an estimated $1.56M.
  • Genpact made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2653 holding.
  • Raymond James Financial first reported a position in Genpact in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Genpact position peaked at $20.8M in Q1 2025.
  • 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.